Advancing Patient Care Award

1. These awards are intended to recognize psychiatric pharmacists working in the field of mental health care which is inclusive of substance use disorders. Posthumous awards will not be allowed.
2. Current members of the AAPP Board of Directors and Nominations and Awards Committee are not eligible for consideration. Members of the Nominations and Awards Committee are also not allowed to nominate or participate in the nomination of a candidate and must recuse themselves if consideration of any candidates represents a conflict of interest for them.
3. Recipients can only be awarded each member recognition award one time and may receive only one recognition award per year. Strategic goal awards can be awarded to the same individual more than once and can be awarded to an individual the same year they receive a member recognition award.
4. Judith J. Saklad Memorial Award recipients are not eligible for consideration of any other AAPP member recognition awards given that the Saklad Award is a pinnacle award and broadly encompasses the various components of other AAPP recognition awards.
5. With the exception of the Saklad Award which is by nomination only, the other awards can be submitted by the applicant or through nomination by others. Regardless of the method, all required elements must be submitted for award consideration by the committee.
6. Though each award is offered annually, the committee is not mandated to select an award recipient each year.
7. Incomplete and/or late applications will not be considered.
8. Applications must be submitted in PDF form to info@aapp.org by the deadline.
9. Notification of awards will occur on or before the end of January.

1. Nominee has been an AAPP member for at least 3 of the past 5 years preceding submission for the award, including the current year of the submission.
2. Board certification as a Board-Certified Psychiatric Pharmacist (BCPP) is not required but will be weighted in award scoring.
3. Applications should only be submitted for nominees who have developed and led patient mental health care programs or efforts that exceed the usual/standard expectations of a psychiatric pharmacist or their job role.
4. This award is intended to recognize an individual AAPP member leading a program, effort, or activity that involves or involved 2 or more of the following:
   1. Interprofessional collaboration to advance the care of persons with mental illness, particularly increasing access to care.
   2. Resource development leading to increased sustainable access to high quality mental health care for patients (e.g., patient assistance programs or other mechanisms).
   3. Design and implementation of unique delivery methods to provide mental health care in communities without reliable access to care (e.g., rural, disadvantaged, etc. communities).
   4. Creation and implementation of mechanisms to proactively limit impact of social determinants of health on people living with mental illness.
   5. Development and rollout of programs to increase access to novel psychotherapeutic treatments for persons with mental illness.
   6. The conduct of research that supports the model of care increasing access to high quality mental health care, particularly involving a psychiatric pharmacist.
5. The program must have been initiated within the preceding five (5) years of submitting for the award.
6. The program, effort, or activity must have resulted in impact at the local, state, or national level with demonstrated outcomes, as described in a publication or through other public dissemination (posters, presentations, etc.) of the program.

This award is intended to recognize psychiatric pharmacists working in the field of mental health care which is inclusive of substance use disorders. Nominations for this awards can be made by the applicant themselves or an individual(s) who wishes to nominate and submit the required elements for consideration by the committee.

Materials are required to be submitted as one PDF file and include:

1. CV
2. Cover Letter: Describing how the effort or activity meets or exceeds the above criteria as well as how the nominee, led, significantly impacted, or enabled the initiative/activity and the realized outcomes. The letter should also specifically address criteria 3, 4, and 5 above, and introduce the relevance of the publication(s) or other scholarly work(s) required for criteria 6. Information on the total number of patients impacted by the program, as well as degree of that impact should be described. Listing of related publication(s) or supporting poster(s) should be included. Publication(s) and other supporting scholarship directly related to the effort/activity must be from within the previous three (3) years. The cover letter should not exceed four (4) single spaced pages.
3. Letter of Support: From a colleague or team member with direct visibility into the quality, uniqueness, and impact of the activity, program, or initiative being nominated as well as the leadership of the psychiatric pharmacist applying for the award. The letter should not exceed 3 pages single spaced and should specifically address how the program and the pharmacist nominated meet criteria 3 and 4 above.